Show simple item record

dc.contributor.authorTheocharous, G.en
dc.contributor.authorPapaspyropoulos, A.en
dc.contributor.authorGorgoulis, Vassilis Gen
dc.date.accessioned2023-08-09T10:07:31Z
dc.date.available2023-08-09T10:07:31Z
dc.date.issued2023en
dc.identifier.citationTheocharous G, Papaspyropoulos A, Gorgoulis V. The survival of curaxins in the cancer arena. BioEssays : news and reviews in molecular, cellular and developmental biology. 2023 Jul 11:e2300112. PubMed PMID: 37431695. Epub 2023/07/11. eng.en
dc.identifier.pmid37431695en
dc.identifier.doi10.1002/bies.202300112en
dc.identifier.urihttp://hdl.handle.net/10541/626451
dc.description.abstractWith DNA damage being a primary anti-cancertarget, a need has arisen for the development of an approach that is a harmlessfor normal tissues but allows for cancer cell-specific cytotoxicity. Previous researchfrom K. Gurova's suggests that small compounds, namely curaxins that bind theDNA can cause chromatin instability and cell death in a cancer cell-specificmanner. In this brief perspective commentary, we investigate how the scientificcommunity has further developed this anti-cancer approach.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1002/bies.202300112en
dc.titleThe survival of curaxins in the cancer arenaen
dc.typeArticleen
dc.contributor.departmentDepartment of Histology and Embryology, Molecular Carcinogenesis Group, Medical School, National Kapodistrian University of Athens, Athens, Greeceen
dc.identifier.journalBioessaysen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record